What Is Gingival Hyperplasia and How Is It Treated?

Gingival hyperplasia is an abnormal overgrowth of gum tissue that partially or fully covers tooth surfaces in severe cases. It is a tissue response to an underlying trigger commonly long-term medication use, chronic plaque accumulation, hormonal changes, or systemic conditions such as leukaemia or Crohn’s disease. The enlarged tissue creates false pockets that trap plaque, accelerating periodontal disease. Appearance varies from firm, pale pink fibrous tissue in drug-induced cases to soft, red, and bleeding tissue in inflammation-driven presentations.

According to Dr. Jaydev, a leading dental clinic in Hyderabad, “gingival overgrowth gets dismissed as a cosmetic problem far too often, but the false pockets it creates are impossible for patients to clean and actively drive bone loss underneath tissue that looks intact from the outside.”

Gingival hyperplasia has distinct, identifiable causes and the tissue characteristics differ significantly depending on which trigger is driving the overgrowth.

• Drug-Induced Overgrowth: Calcium channel blockers like amlodipine, anticonvulsants like phenytoin, and immunosuppressants like cyclosporine are the three most common drug classes producing firm fibrous gum enlargement, affecting roughly 50 percent of long-term phenytoin users
• Chronic Plaque Accumulation: Persistent bacterial biofilm at the gumline sustains a low-grade inflammatory response that drives gingival volume increase over months, and the enlarged tissue then traps more plaque, creating a self-reinforcing cycle that worsens without professional intervention
• Hormonal Changes: Pregnancy, puberty, and hormonal contraceptive use alter gingival vascular response to plaque, producing soft oedematous overgrowth that can appear rapidly and regress partially after the hormonal trigger resolves
• Systemic Disease: Leukaemia produces gingival infiltration by malignant cells that clinically resembles inflammatory hyperplasia, and Crohn’s disease causes firm cobblestone-textured gingival changes that are often the first visible sign of the systemic condition

Identifying the correct cause determines the entire treatment pathway, and patients presenting with unexplained overgrowth benefit from the diagnostic workup routinely done at the smile design clinic in Hyderabad before any surgical plan is made.

Treatment isn’t one-size-fits-all here. The approach depends entirely on the cause, the severity of tissue involvement, and whether the underlying trigger can be removed or modified.

• Medication Review: Drug-induced hyperplasia often reduces significantly after switching to an alternative medication in consultation with the prescribing physician, and this step is always explored before any surgical tissue removal is considered
• Professional Scaling: Thorough debridement removes the plaque and calculus sustaining the inflammatory component, and in mild to moderate cases where plaque is the primary driver, tissue volume reduces meaningfully within six to eight weeks of consistent periodontal treatment
• Gingivectomy: Surgical removal of excess gum tissue using a scalpel or laser restores normal gingival contour, eliminates false pockets, and exposes tooth surfaces for proper cleaning, with laser gingivectomy offering reduced bleeding and faster healing compared to conventional surgery
• Systemic Referral: Hyperplasia linked to leukaemia, Crohn’s disease, or other systemic conditions requires concurrent medical management, and periodontal treatment alone produces temporary results if the underlying disease driving the tissue response remains uncontrolled

Recurrence is the most important factor to plan around, and patients who’ve had surgical correction without addressing the original cause consistently return with regrowth, which is why reading about single tooth implant vs dental bridge only scratches the surface of how interconnected untreated periodontal triggers are across every restoration decision.

Dr. Jaydev is a specialist at the smile makeover in Hyderabad centre with advanced training in periodontal surgery, laser gingivectomy, and systemic disease-related gingival conditions, bringing extensive clinical experience managing drug-induced, inflammatory, and hormonally driven gingival overgrowth across patients with varying degrees of tissue involvement and bone loss.

Cases here don’t go straight to surgery. Cause identification, medication review coordination, and plaque control stabilisation come first, so patients aren’t cycling through repeated gingivectomies because the trigger driving regrowth was never properly addressed.

1. Bharti V & Bansal C (2013) Drug-induced gingival overgrowth: The nemesis of gingiva unravelled
2. Trackman PC & Kantarci A (2015) Molecular and Clinical Aspects of Drug-induced Gingival Overgrowth